MARKET WIRE NEWS
  1. Home
  2. Stock
  3. STOK
  4. News
STOK
Quote
Short
News
Articles
Message Board

Stoke Therapeutics Inc. (NASDAQ : STOK ) News

News Releases

STOK News Releases
STOK : NASDAQ
Business Wire
Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
STOK : NASDAQ
SeekingAlpha
Stoke Therapeutics, Inc. (STOK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
STOK : NASDAQ
Business Wire
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
STOK : NASDAQ
SeekingAlpha
Stoke outlines Q1 2027 rolling NDA start as EMPEROR enrollment targets June, backed by $411M cash balance
STOK : NASDAQ
SeekingAlpha
Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript
STOK : NASDAQ
SeekingAlpha
Stoke Therapeutics GAAP EPS of -$0.79 beats by $0.05, revenue of $6.2M beats by $1.07M
STOK : NASDAQ
Business Wire
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
STOK : NASDAQ
SeekingAlpha
Stoke Therapeutics: Zorevunersen Has Disease-Modifying Potential In Dravet Syndrome
STOK : NASDAQ
Business Wire
Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates
STOK : NASDAQ
Business Wire
Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.